Physiotherapist Navigator Pilot Trial
Launched by MCMASTER UNIVERSITY · Jun 23, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to support people living with cancer by introducing a special role called a Physiotherapist (PT) Navigator. This person would regularly check in with patients during their cancer treatment to help manage common side effects like fatigue and muscle weakness. The PT Navigator would also guide patients to other helpful services and work with them to set goals that improve their overall quality of life. Right now, this kind of support isn’t routinely offered in cancer care in Canada, so this study aims to see if it’s possible and helpful to add it.
Adults aged 18 or older who have recently been diagnosed with any type of cancer and are starting or receiving treatments like chemotherapy, radiation, or immunotherapy may be eligible to join. Participants must speak English and live in the community (not in a hospital or care facility). Those with physical or cognitive difficulties that make it hard to do a physical assessment won’t be able to participate. If you join the study, you may be assigned to work with the PT Navigator for 12 to 18 weeks, who will regularly check your health and help manage side effects. Others will continue with their usual care. The study will look at how well this new support role works and how satisfied people are with it, which could help improve cancer care in Canada and beyond in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults aged ≥18 years old; recently diagnosed with any type/stage of cancer who are/will be receiving cancer treatment (e.g., chemotherapy, radiation, immunotherapy); English-speaking; are community-dwelling
- Exclusion Criteria:
- • have a self-reported physical or cognitive impairment that would prevent them from carrying out a physical assessment
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Ontario, Canada
Patients applied
Trial Officials
Jenna Smith-Turchyn, PT, PhD
Principal Investigator
McMaster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported